BioSourcing announces expansion of partnership with Zoetis to produce biopharmaceuticals for Animal Health market


Zoetis and Bio-Sourcing, an animal health Biotech headquartered in Liege, Belgium, are expanding a research partnership, started in 2012, to produce biopharmaceuticals for animal health market. The companies are exploring the potential of BioSourcing’s unique bio-production technology platform to help manufacture complex therapeutic proteins such as monoclonal antibodies in large volumes at potentially reduced costs. Through this collaboration, BioSourcing will adapt for animal health use the rPRO® technology platform, under exclusive license from strategic partner LFB and already validated in human health applications. The company will apply this technology to producing monoclonal antibodies for use in different animal health species.

For more information about Zoetis, please visit

No Comments

Post a Comment